NCT05942872View on ClinicalTrials.gov

CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

July 15, 2021

Study Completion Date

September 15, 2021

Conditions
Paraneoplastic Syndromes
Interventions
OTHER

This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.

This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.

Trial Locations (1)

69677

Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT05942872 - CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival. | Biotech Hunter | Biotech Hunter